Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie sheds autoimmune disease drug in blow to partner Inventiva
Pharmaphorum
Mon, 10/31/22 - 10:21 am
AbbVie
autoimmune disease
Inventiva
cedirogant
AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now
Endpoints
Sun, 10/30/22 - 04:22 pm
AbbVie
Humira
patents
biosimilars
earnings
patent cliff
AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy
BioSpace
Thu, 10/20/22 - 11:29 pm
AbbVie
M&A
DJS Antibodies
pulmonary fibrosis
antibodies
What Pharma Companies Can Expect From the Influx of Humira Biosimilars
Drug Channels
Fri, 10/14/22 - 10:15 am
AbbVie
Humira
biosimilars
Amgen
Amjevita
BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica
Fierce Pharma
Wed, 10/12/22 - 11:00 am
BeiGene
AbbVie
JNJ
Imbruvica
blood cancers
Brukinsa
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
layoffs
Cyclerion
OncoSec
Exicure
AbbVie
Bristol Myers Squibb
Palisade Bio
ObsEva
Rubius Therapeutics
Novartis
Finch Therapeutics
Q3 2022: Layoffs Continue, Alzheimer’s Soars and Accelerated Approvals Fall
BioSpace
Mon, 10/3/22 - 11:33 pm
layoffs
Vesalius Therapeutics
AbbVie
Bristol Myers Squibb
Palisade Bio
IBV
Zymergen
Where Will AbbVie Be in 3 Years?
Motley Fool
Fri, 09/30/22 - 10:50 am
AbbVie
Humira
biosimilars
Rinvoq
Skyrizi
Vraylar
As lead drug flopped and AbbVie collab dissolved, cancer biotech resorts to buying rare disease company
Endpoints
Thu, 09/29/22 - 10:02 am
Idera Pharmaceuticals
AbbVie
Aceragen
M&A
AbbVie and BMS slash 360 jobs in California, the latest in a streak of biopharma layoffs
Fierce Pharma
Sun, 09/18/22 - 10:45 pm
AbbVie
Bristol Myers Squibb
layoffs
California
AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved
Endpoints
Tue, 09/13/22 - 08:06 pm
AbbVie
Allergan
Botox
DTC ads
Daxxify
Revance Therapeutics
Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?
Fierce Pharma
Tue, 09/13/22 - 08:03 pm
Novartis
FDA
Cosentyx
AbbVie
Humira
hidradenitis suppurativa
Longer-lasting Botox competitor nabs FDA approval — can it compete with AbbVie's $2B cash cow?
Endpoints
Thu, 09/8/22 - 11:04 am
Revance Therapeutics
FDA
Daxxify
aesthetics
AbbVie
Botox
FDA holds back Alvotech’s Humira biosimilar over manufacturing issues
BioPharma Dive
Tue, 09/6/22 - 04:57 pm
Alvotech
AbbVie
Humira
biosimilars
FDA
drug manufacturing
Kymera’s pain could be Priovant’s gain
EP Vantage
Tue, 08/30/22 - 11:41 am
Pfizer
hidradenitis suppurativa
Kymera
Priovant
AbbVie
AbbVie fends off patent claim in unusual whistleblower case
Fierce Pharma
Fri, 08/26/22 - 12:18 pm
AbbVie
whistleblower lawsuits
whistleblowers
Allergan
Adamas
Alzheimer's disease
AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease
Fierce Pharma
Thu, 08/25/22 - 11:04 am
JNJ
AbbVie
Imbruvica
graft vs host disease
pediatric
FDA
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
Tue, 08/16/22 - 11:59 pm
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Fierce Biotech
Wed, 08/10/22 - 10:49 am
Innovent
AbbVie
JNJ
monoclonal antibodies
psoriasis
clinical trials
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »